Búsqueda | Portal de Búsqueda de la BVS

1.

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.

Ridker, Paul M; Bhatt, Deepak L; Pradhan, Aruna D; Glynn, Robert J; MacFadyen, Jean G; Nissen, Steven E.

Lancet ; 401(10384): 1293-1301, 2023 04 15.

Artículo en Inglés | MEDLINE | ID: mdl-36893777

2.

Elevated lipoprotein(a) as a predictor for coronary events in older men.

Bartoli-Leonard, Francesca; Turner, Mandy E; Zimmer, Jonas; Chapurlat, Roland; Pham, Tan; Aikawa, Masanori; Pradhan, Aruna D; Szulc, Pawel; Aikawa, Elena.

J Lipid Res ; 63(8): 100242, 2022 08.

Artículo en Inglés | MEDLINE | ID: mdl-35724702

3.

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.

Levin, Michael G; Zuber, Verena; Walker, Venexia M; Klarin, Derek; Lynch, Julie; Malik, Rainer; Aday, Aaron W; Bottolo, Leonardo; Pradhan, Aruna D; Dichgans, Martin; Chang, Kyong-Mi; Rader, Daniel J; Tsao, Philip S; Voight, Benjamin F; Gill, Dipender; Burgess, Stephen; Damrauer, Scott M.

Circulation ; 144(5): 353-364, 2021 08 03.

Artículo en Inglés | MEDLINE | ID: mdl-34139859

4.

Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association.

Creager, Mark A; Matsushita, Kunihiro; Arya, Shipra; Beckman, Joshua A; Duval, Sue; Goodney, Philip P; Gutierrez, J Antonio T; Kaufman, John A; Joynt Maddox, Karen E; Pollak, Amy W; Pradhan, Aruna D; Whitsel, Laurie P.

Circulation ; 143(17): e875-e891, 2021 04 27.

Artículo en Inglés | MEDLINE | ID: mdl-33761757

5.

Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women.

Aday, Aaron W; Duran, Edward K; Van Denburgh, Martin; Kim, Eunjung; Christen, William G; Manson, JoAnn E; Ridker, Paul M; Pradhan, Aruna D.

Arterioscler Thromb Vasc Biol ; 41(7): 2215-2224, 2021 07.

Artículo en Inglés | MEDLINE | ID: mdl-34039021

6.

Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.

Henke, Peter K; Kahn, Susan R; Pannucci, Christopher J; Secemksy, Eric A; Evans, Natalie S; Khorana, Alok A; Creager, Mark A; Pradhan, Aruna D.

Circulation ; 141(24): e914-e931, 2020 06 16.

Artículo en Inglés | MEDLINE | ID: mdl-32375490

7.

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.

Duran, Edward K; Pradhan, Aruna D.

Clin Chem ; 67(1): 183-196, 2021 01 08.

Artículo en Inglés | MEDLINE | ID: mdl-33409533

8.

Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.

Solomon, Daniel H; Glynn, Robert J; Karlson, Elizabeth W; Lu, Fengxin; Corrigan, Cassandra; Colls, Josh; Xu, Chang; MacFadyen, Jean; Barbhaiya, Medha; Berliner, Nancy; Dellaripa, Paul F; Everett, Brendan M; Pradhan, Aruna D; Hammond, Sarah P; Murray, Meredith; Rao, Deepak A; Ritter, Susan Y; Rutherford, Anna; Sparks, Jeffrey A; Stratton, Jackie; Suh, Dong H; Tedeschi, Sara K; Vanni, Kathleen M M; Paynter, Nina P; Ridker, Paul M.

Ann Intern Med ; 172(6): 369-380, 2020 03 17.

Artículo en Inglés | MEDLINE | ID: mdl-32066146

9.

Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy.

Pradhan, Aruna D; Aday, Aaron W; Rose, Lynda M; Ridker, Paul M.

Circulation ; 138(2): 141-149, 2018 07 10.

Artículo en Inglés | MEDLINE | ID: mdl-29716940

10.

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.

Aday, Aaron W; Lawler, Patrick R; Cook, Nancy R; Ridker, Paul M; Mora, Samia; Pradhan, Aruna D.

Circulation ; 138(21): 2330-2341, 2018 11 20.

Artículo en Inglés | MEDLINE | ID: mdl-30021845

11.

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Pradhan, Aruna D; Paynter, Nina P; Everett, Brendan M; Glynn, Robert J; Amarenco, Pierre; Elam, Marshall; Ginsberg, Henry; Hiatt, William R; Ishibashi, Shun; Koenig, Wolfgang; Nordestgaard, Børge G; Fruchart, Jean-Charles; Libby, Peter; Ridker, Paul M.

Am Heart J ; 206: 80-93, 2018 12.

Artículo en Inglés | MEDLINE | ID: mdl-30342298

12.

Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?

Pradhan, Aruna D.

Eur Heart J ; 42(28): 2776-2779, 2021 07 21.

Artículo en Inglés | MEDLINE | ID: mdl-33824963

13.

The Big MAC Attack on Peripheral Artery Disease.

Pradhan, Aruna D; Aday, Aaron W; Beckman, Joshua A.

Circulation ; 141(15): 1211-1213, 2020 04 14.

Artículo en Inglés | MEDLINE | ID: mdl-32282252

14.

Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.

Akinkuolie, Akintunde O; Pradhan, Aruna D; Buring, Julie E; Ridker, Paul M; Mora, Samia.

Arterioscler Thromb Vasc Biol ; 35(6): 1544-50, 2015 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-25908766

15.

A New Beginning for Triglyceride-Lowering Therapies.

Pradhan, Aruna D.

Circulation ; 140(3): 167-169, 2019 07 16.

Artículo en Inglés | MEDLINE | ID: mdl-30836784

16.

Sex differences in the metabolic syndrome: implications for cardiovascular health in women.

Pradhan, Aruna D.

Clin Chem ; 60(1): 44-52, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-24255079

17.

Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.

Everett, Brendan M; Pradhan, Aruna D; Solomon, Daniel H; Paynter, Nina; Macfadyen, Jean; Zaharris, Elaine; Gupta, Milan; Clearfield, Michael; Libby, Peter; Hasan, Ahmed A K; Glynn, Robert J; Ridker, Paul M.

Am Heart J ; 166(2): 199-207.e15, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23895801

18.

Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women.

Everett, Brendan M; Cook, Nancy R; Chasman, Daniel I; Magnone, Maria C; Bobadilla, Maria; Rifai, Nader; Ridker, Paul M; Pradhan, Aruna D.

Clin Chem ; 59(3): 557-65, 2013 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-23288489

19.

Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies: JACC Focus Seminar 3/3.

Malick, Waqas A; Waksman, Ori; Do, Ron; Koenig, Wolfgang; Pradhan, Aruna D; Stroes, Erik S G; Rosenson, Robert S.

J Am Coll Cardiol ; 81(16): 1646-1658, 2023 04 25.

Artículo en Inglés | MEDLINE | ID: mdl-37076219

20.

C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.

Burger, Pascal M; Pradhan, Aruna D; Dorresteijn, Jannick A N; Koudstaal, Stefan; Teraa, Martin; de Borst, Gert J; van der Meer, Manon G; Mosterd, Arend; Ridker, Paul M; Visseren, Frank L J.

Am J Cardiol ; 197: 13-23, 2023 06 15.

Artículo en Inglés | MEDLINE | ID: mdl-37218417

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.

Elevated lipoprotein(a) as a predictor for coronary events in older men.

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease.

Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association.

Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women.

Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease.

Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.

Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy.

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?

The Big MAC Attack on Peripheral Artery Disease.

Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.

A New Beginning for Triglyceride-Lowering Therapies.

Sex differences in the metabolic syndrome: implications for cardiovascular health in women.

Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.

Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women.

Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies: JACC Focus Seminar 3/3.

C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.